Skip to main content
Carisma Therapeutics, Inc. (CARM)
NASDAQ: CARM · Real-Time Price · USD
1.030
-0.080 (-7.21%)
At close: Nov 7, 2024, 4:00 PM
1.080
+0.050 (4.85%)
After-hours: Nov 7, 2024, 6:07 PM EST

Carisma Therapeutics Revenue

Carisma Therapeutics had revenue of $9.20M in the quarter ending June 30, 2024, with 158.34% growth. This brings the company's revenue in the last twelve months to $20.71M, up 57.95% year-over-year. In the year 2023, Carisma Therapeutics had annual revenue of $14.92M with 51.71% growth.

Revenue (ttm)
$20.71M
Revenue Growth
+57.95%
P/S Ratio
2.19
Revenue / Employee
$193,551
Employees
107
Market Cap
42.79M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202314.92M5.09M51.71%
Dec 31, 20229.83M--
Dec 31, 2021---
Dec 31, 2020---
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

CARM News

More News